Table 2.
Univariate and multivariate Cox regression analyses of overall survival and disease-free survival in GC patients.
| Variables | Univariate analyses | Multivariate analyses | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | |
| Overall survival | ||||||
| Age (years) ≥ 60/<60 | 0.805 | 0.638–1.169 | 0.881 | — | — | — |
| Gender Male/female | 0.942 | 0.596–1.283 | 0.755 | — | — | — |
| Tumor size (cm) ≥ 5/<5 | 1.753 | 1.279–2.861 | 0.018 | 2.097 | 1.192–2.252 | 0.036 |
| Differentiation grade Poor+ moderate/well | 3.134 | 1.369–3.693 | 0.007 | 2.013 | 1.145–2.598 | 0.016 |
| TNM stage III/I + II | 1.547 | 0.546–2.286 | 0.398 | — | — | — |
| Depth of invasion pT3-4/pT1-2 | 1.783 | 0.693–3.810 | 0.332 | — | — | — |
| Lymph node metastasis Yes/no | 2.842 | 1.361–2.578 | 0.033 | 2.333 | 1.567–2.679 | 0.045 |
| Distant metastasis Yes/no | 3.161 | 1.527–3.967 | 0.013 | 1.783 | 0.574–2.788 | 0.357 |
| CEA, µg/ml ≥ 4.5/<4.5 | 1.807 | 0.837–3.835 | 0.273 | — | — | — |
| CA19-9, kU/L ≥ 40/<40 | 1.655 | 0.973–3.691 | 0.803 | — | — | — |
| MiR-520f-3p expression low/high | 2.31 | 1.524–3.429 | 0.025 | 1.946 | 1.256–2.678 | 0.031 |
| Disease-free survival | ||||||
| Age (years) ≥ 60/<60 | 0.854 | 0.525–1.809 | 0.624 | — | — | — |
| Gender Male/female | 0.742 | 0.739–1.507 | 0.203 | — | — | — |
| Tumor size (cm) ≥ 5/<5 | 1.265 | 0.562-2.952 | 0.815 | — | — | — |
| Differentiation grade Poor+ moderate/well | 3.798 | 1.337–3.531 | 0.034 | 1.525 | 1.545–2.852 | 0.041 |
| TNM stage III/I + II | 1.891 | 0.818–2.437 | 0.825 | — | — | — |
| Depth of invasion pT3-4/pT1-2 | 1.827 | 1.236–2.099 | 0.017 | 1.901 | 1.311–2.633 | 0.027 |
| Lymph node metastasis Yes/no | 3.272 | 1.433–4.629 | 0.018 | 1.587 | 1.211–2.094 | 0.021 |
| Distant metastasis Yes/no | 2.357 | 1.307–3.752 | 0.015 | 2.464 | 1.238–2.359 | 0.047 |
| CEA, µg/ml ≥ 4.5/<4.5 | 1.676 | 0.804–1.122 | 0.107 | — | — | — |
| CA19-9, kU/L ≥ 40/<40 | 1.423 | 0.457–1.669 | 0.438 | — | — | — |
| MiR-520f-3p expression low/high | 2.225 | 1.896–3.833 | 0.013 | 1.876 | 1.292–2.867 | 0.039 |
CA19-9 carbohydrate antigen 19-9; HR, hazard ratio; 95% CI, 95% confidence interval.